Clearmind Medicine Common Stock Price History
| CMND Stock | USD 1.25 0.05 3.85% |
If you're considering investing in Clearmind Stock, it is important to understand the factors that can impact its price. As of today, the current price of Clearmind Medicine stands at 1.25, as last reported on the 3rd of December, with the highest price reaching 1.30 and the lowest price hitting 1.25 during the day. At this point, Clearmind Medicine is extremely dangerous. Clearmind Medicine Common secures Sharpe Ratio (or Efficiency) of 0.0252, which signifies that the company had a 0.0252% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Clearmind Medicine Common, which you can use to evaluate the volatility of the firm. Please confirm Clearmind Medicine's risk adjusted performance of 0.019, and Mean Deviation of 3.62 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%.
At present, Clearmind Medicine's Common Stock is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 5.2 M, whereas Other Stockholder Equity is forecasted to decline to about 1.6 M. . At present, Clearmind Medicine's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.51, whereas Price To Operating Cash Flows Ratio is projected to grow to (0.15). Clearmind Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Clearmind |
Sharpe Ratio = 0.0252
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.05 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 1 99% of assets perform better |
Based on monthly moving average Clearmind Medicine is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearmind Medicine by adding it to a well-diversified portfolio.
Price Book 1.524 | Book Value 0.873 | Enterprise Value -2.3 M | Enterprise Value Ebitda (0.79) | Shares Float 3.6 M |
Clearmind Medicine Stock Price History Chart
There are several ways to analyze Clearmind Stock price data. The simplest method is using a basic Clearmind candlestick price chart, which shows Clearmind Medicine price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 18, 2024 | 1.76 |
| Lowest Price | October 2, 2024 | 1.2 |
Clearmind Medicine December 3, 2024 Stock Price Synopsis
Various analyses of Clearmind Medicine's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Clearmind Stock. It can be used to describe the percentage change in the price of Clearmind Medicine from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Clearmind Stock.| Clearmind Medicine Price Action Indicator | (0.05) | |
| Clearmind Medicine Price Daily Balance Of Power | (1.00) | |
| Clearmind Medicine Price Rate Of Daily Change | 0.96 |
Clearmind Medicine December 3, 2024 Stock Price Analysis
Clearmind Stock Price History Data
The price series of Clearmind Medicine for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 has a statistical range of 0.56 with a coefficient of variation of 7.96. The prices are distributed with arithmetic mean of 1.36. The median price for the last 90 days is 1.34. The company had 1:30 stock split on 28th of November 2023.| Open | High | Low | Close | Volume | ||
12/03/2024 | 1.29 | 1.30 | 1.25 | 1.25 | ||
| 12/02/2024 | 1.29 | 1.30 | 1.25 | 1.25 | 55,341 | |
| 11/29/2024 | 1.30 | 1.32 | 1.28 | 1.30 | 19,054 | |
| 11/27/2024 | 1.35 | 1.35 | 1.27 | 1.28 | 61,198 | |
| 11/26/2024 | 1.33 | 1.35 | 1.32 | 1.33 | 13,749 | |
| 11/25/2024 | 1.35 | 1.36 | 1.31 | 1.33 | 31,203 | |
| 11/22/2024 | 1.33 | 1.36 | 1.33 | 1.33 | 17,878 | |
| 11/21/2024 | 1.36 | 1.37 | 1.30 | 1.34 | 35,116 | |
| 11/20/2024 | 1.32 | 1.39 | 1.29 | 1.36 | 72,626 | |
| 11/19/2024 | 1.33 | 1.35 | 1.31 | 1.34 | 40,199 | |
| 11/18/2024 | 1.38 | 1.39 | 1.31 | 1.33 | 94,586 | |
| 11/15/2024 | 1.47 | 1.53 | 1.34 | 1.34 | 283,529 | |
| 11/14/2024 | 1.50 | 1.52 | 1.39 | 1.47 | 207,177 | |
| 11/13/2024 | 1.50 | 1.53 | 1.45 | 1.47 | 88,689 | |
| 11/12/2024 | 1.54 | 1.56 | 1.45 | 1.53 | 103,475 | |
| 11/11/2024 | 1.49 | 1.58 | 1.46 | 1.56 | 188,674 | |
| 11/08/2024 | 1.40 | 1.57 | 1.35 | 1.54 | 499,615 | |
| 11/07/2024 | 1.40 | 1.40 | 1.35 | 1.40 | 41,814 | |
| 11/06/2024 | 1.41 | 1.41 | 1.35 | 1.35 | 163,116 | |
| 11/05/2024 | 1.43 | 1.45 | 1.38 | 1.41 | 73,476 | |
| 11/04/2024 | 1.37 | 1.45 | 1.33 | 1.40 | 87,836 | |
| 11/01/2024 | 1.40 | 1.42 | 1.34 | 1.36 | 63,676 | |
| 10/31/2024 | 1.47 | 1.50 | 1.36 | 1.39 | 51,826 | |
| 10/30/2024 | 1.45 | 1.48 | 1.45 | 1.46 | 23,031 | |
| 10/29/2024 | 1.46 | 1.52 | 1.37 | 1.47 | 82,479 | |
| 10/28/2024 | 1.47 | 1.50 | 1.42 | 1.42 | 40,091 | |
| 10/25/2024 | 1.54 | 1.59 | 1.45 | 1.46 | 110,288 | |
| 10/24/2024 | 1.43 | 1.57 | 1.42 | 1.54 | 162,171 | |
| 10/23/2024 | 1.48 | 1.52 | 1.39 | 1.43 | 196,854 | |
| 10/22/2024 | 1.52 | 1.54 | 1.41 | 1.48 | 171,355 | |
| 10/21/2024 | 1.78 | 1.78 | 1.53 | 1.54 | 566,794 | |
| 10/18/2024 | 1.39 | 1.81 | 1.35 | 1.76 | 2,296,540 | |
| 10/17/2024 | 1.39 | 1.45 | 1.32 | 1.32 | 128,064 | |
| 10/16/2024 | 1.60 | 1.60 | 1.32 | 1.43 | 805,407 | |
| 10/15/2024 | 1.42 | 1.68 | 1.35 | 1.59 | 2,648,122 | |
| 10/14/2024 | 1.33 | 1.47 | 1.31 | 1.41 | 328,020 | |
| 10/11/2024 | 1.29 | 1.38 | 1.24 | 1.36 | 359,168 | |
| 10/10/2024 | 1.30 | 1.38 | 1.25 | 1.36 | 4,667,507 | |
| 10/09/2024 | 1.32 | 1.41 | 1.32 | 1.40 | 28,181 | |
| 10/08/2024 | 1.29 | 1.45 | 1.28 | 1.32 | 99,895 | |
| 10/07/2024 | 1.21 | 1.34 | 1.21 | 1.33 | 109,156 | |
| 10/04/2024 | 1.22 | 1.25 | 1.21 | 1.23 | 7,937 | |
| 10/03/2024 | 1.20 | 1.26 | 1.20 | 1.24 | 28,825 | |
| 10/02/2024 | 1.20 | 1.25 | 1.19 | 1.20 | 54,345 | |
| 10/01/2024 | 1.24 | 1.24 | 1.20 | 1.21 | 21,511 | |
| 09/30/2024 | 1.23 | 1.25 | 1.22 | 1.22 | 23,300 | |
| 09/27/2024 | 1.22 | 1.25 | 1.22 | 1.25 | 25,670 | |
| 09/26/2024 | 1.24 | 1.26 | 1.22 | 1.24 | 31,254 | |
| 09/25/2024 | 1.21 | 1.26 | 1.21 | 1.26 | 22,224 | |
| 09/24/2024 | 1.21 | 1.26 | 1.21 | 1.23 | 39,143 | |
| 09/23/2024 | 1.23 | 1.27 | 1.20 | 1.21 | 35,674 | |
| 09/20/2024 | 1.26 | 1.29 | 1.21 | 1.21 | 29,915 | |
| 09/19/2024 | 1.30 | 1.34 | 1.27 | 1.29 | 60,134 | |
| 09/18/2024 | 1.33 | 1.34 | 1.31 | 1.32 | 60,302 | |
| 09/17/2024 | 1.36 | 1.36 | 1.26 | 1.34 | 57,299 | |
| 09/16/2024 | 1.37 | 1.37 | 1.30 | 1.33 | 125,491 | |
| 09/13/2024 | 1.33 | 1.36 | 1.31 | 1.34 | 16,111 | |
| 09/12/2024 | 1.32 | 1.40 | 1.28 | 1.32 | 166,124 | |
| 09/11/2024 | 1.32 | 1.33 | 1.29 | 1.30 | 85,565 | |
| 09/10/2024 | 1.37 | 1.38 | 1.32 | 1.33 | 52,442 | |
| 09/09/2024 | 1.27 | 1.37 | 1.27 | 1.37 | 94,229 |
About Clearmind Medicine Stock history
Clearmind Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Clearmind is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Clearmind Medicine Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Clearmind Medicine stock prices may prove useful in developing a viable investing in Clearmind Medicine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 232.9 K | 244.5 K | |
| Net Loss | -8.5 M | -8 M |
Clearmind Medicine Quarterly Net Working Capital |
|
Clearmind Medicine Stock Technical Analysis
Clearmind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Clearmind Medicine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Clearmind Medicine's price direction in advance. Along with the technical and fundamental analysis of Clearmind Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Clearmind to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.019 | |||
| Jensen Alpha | 0.052 | |||
| Total Risk Alpha | (0.83) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.4278 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |